Young Lee
Neurology with Special Qualifications in Child Neurology · Tucson, AZNPI 1093945883
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Livanova USA, Inc. at 50.9% of the total. Reporting peaked in 2020 at $1,458 and has fallen 86.6% since, to $195 in 2025.
Across 57 payments — averaging $49.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$1K
- Jazz Pharmaceuticals Inc.$230
- UCB, Inc.$213
- Immedica Pharma US, Inc.$128
- Vericel Corporation$119
- Acadia Pharmaceuticals Inc$111
- plus $592 from 18 others
What the payments were for
- Travel & lodging$1,26144%
- Food & beverage$1,57355%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 5 | $1,444 |
| Jazz Pharmaceuticals Inc. | 7 | $230 |
| UCB, Inc. | 10 | $213 |
| Immedica Pharma US, Inc. | 1 | $128 |
| Vericel Corporation | 1 | $119 |
| Acadia Pharmaceuticals Inc | 5 | $111 |
| Neurelis, Inc. | 2 | $107 |
| EMD Serono, Inc. | 2 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| Salvin Dental Specialties, Inc. | 1 | $45 |
| Mallinckrodt Hospital Products Inc. | 2 | $40 |
| Greenwich Biosciences, Inc. | 2 | $38 |
| Sunovion Pharmaceuticals Inc. | 3 | $35 |
| AstraZeneca(2 entities) | 2 | $35 |
| AbbVie | 1 | $26 |
| Zogenix Inc. | 1 | $24 |
| SK Life Science, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Amneal Pharmaceuticals LLC | 1 | $19 |
| Biomarin Pharmaceutical Inc. | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Travere Therapeutics, Inc. | 3 | $15 |
| Advanced Respiratory, Inc | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$1,427
- ZTALMY$128
- MACI$119
How this compares
$2,836 in reported general payments places this provider in the 65th percentile of 49 neurology with special qualifications in child neurology providers in Arizona.
See all neurology with special qualifications in child neurology providers in Arizona →
Other neurology with special qualifications in child neurology in Tucson
- Dinesh TalwarTucson$30K
- Chi DaiTucson$6K
- Nadia FikeTucson$431
- Padmavati EksambeTucson$384
- John GrayTucson$370
- Freddie JosephTucson$337
- Angus WilfongPhoenix$348K
- Clara ChowPhoenix$35K
- Saunder BernesPhoenix$27K
- Randa JarrarPhoenix$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.